WHC is still in active development. Read this to understand our approach.
depiction of PLRACCBDVIHHLZ-UHFFFAOYSA-N.svg
isomerdesign

MPTP

Check on isomerdesign

pubchem

1-Methyl-4-phenyl-1,...

Check on pubchem

drugmap

1-methyl-4-phenyl-1,...

Check on drugmap

Data

InChI: InChI=1S/C12H15N/c1-13-9-7-12(8-10-13)11-5-3-2-4-6-11/h2-7H,8-10H2,1H3

Synonyms: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 97%, 1-Methyl-4-phenyl-1,2,5,6-tetrahydropyridine,NSC-139654,DB-047370,METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE, 1-, CHEMBL24172,BRN 0133712,Pyridine,1,2,3,6-tetrahydro-1-methyl-4-phenyl,1,2,3,6-Tetrahydro-1-methyl-4-phenylpyridine,UNII-9P21XSP91P,Q239816,J-017031,MPTP,1-METHYL-4-PHENYL-PIPERIDINE-3-EN,EINECS 248-939-7,N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine,DTXSID8040933,1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine, free base,NSC 139654,MPTP [MI],1-Methyl-4-phenyl-1,2,3,6-tetrahydroxpyridine,BDBM50003599,CS-0172436,1-Methyl-4-phenyl-1,2,5,6-tetrahydropyridine,PYRIDINE, 1,2,3,6-TETRAHYDRO-1-METHYL-4-PHENYL-,1-methyl-4-phenyl-1,2,3,6-tetrahydro pyridine,CCRIS 2186, MPTP,1-methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine, NSC 139654,CHEMBL24172,FT-0638772, CHEBI:17963, 28289-54-5,CHEBI:17963, PLRACCBDVIHHLZ-UHFFFAOYSA-N, 1-METHYL-4-PHENYL-PIPERIDINE-3-EN, HSDB 6942, EINECS 248-939-7,STK191942,SCHEMBL50923,HSDB 6942,9P21XSP91P,AS-38061,Pyridine,1,2,3,6-tetrahydro-1-methyl-4-phenyl-,1-methyl-4-phenyl-3,6-dihydro-2H-pyridine, UNII-9P21XSP91P,AKOS003657026, 1-Methyl-4-phenyl-1,2,3,6-tetrahydroxpyridine, 1-methyl-4-phenyl-3,6-dihydro-2H-pyridine,NSC139654,A819403, N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine,1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine,1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine,AMY23633, 9P21XSP91P,N-Methyl-4-phenyl-1,2,5,6-tetrahydropyridine, PYRIDINE, 1,2,3,6-TETRAHYDRO-1-METHYL-4-PHENYL-, BRN 0133712,28289-54-5, CCRIS 2186,1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [HSDB],ZINC968184,C04599, 1,2,3,6-Tetrahydro-1-methyl-4-phenylpyridine

Estimated data

Solubility: -1.616 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)

Addictivity Prediction: 48.6% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.